Tibet Pharmaceuticals' first-half 2026 net profit rises 7.16% year on year

EarningsCorporate Action
โดย CLS·CN·Read original
Summary · why it matters

Tibet Pharmaceuticals released its 2026 semi-annual report, with net profit attributable to shareholders of the listed company at 608 million yuan, up 7.16% year on year. The company achieved operating revenue of 1.554 billion yuan in the same period, down 5.83% year on year. In addition, the company plans to distribute a cash dividend of 1.146 yuan per share, tax included, to all shareholders.

Impact on stocks 2

Others▲ · 2 stocks
© 2026 MarketDXNews